Many pregnant women in the U.S. have expressed concern over receiving a COVID-19 vaccine because of the lack of clinical trials done around it.
But a new Harvard survey shows those same concerns are not felt by pregnant women around the world; particularly in India, the Philippines and all counties surveyed in Latin America.
"In Mexico and India, we see 80 percent of women expressing willingness to receive the COVID-19 vaccine, where (in) the U.S. and Russian, the rate is below 45 percent," said Dr. Julie Wu, Principal Investigator for the Human Immunomics Initiative and Research Scientist of Infectious Disease Epidemiology at the Harvard T.H. Chan School of Public Health.
In the study published Monday, trust of public health services and "COVID-19 denial" proved to be an important factor in low ratings from the U.S. and Russia, Dr. Wu told KCBS Radio. Australia and New Zealand also came in with a low acceptance rate, however, researchers believe that can be attributed to low coronavirus case counts.
"Our study confirmed that COVID-19 vaccine hesitancy is multifaceted," she added.
Overall, 52 percent of pregnant women and 73 percent of non-pregnant women said they’d get the vaccine.
Several vaccine trials are underway for pregnant women, including ones run by Pfizer and Johnson & Johnson. According to the Centers for Disease Control and Prevention, currently "only limited data are available on the safety of COVID-19 vaccines...administered during pregnancy."